Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(23)00467-9
Publication URI: http://dx.doi.org/10.1016/s2214-109x(23)00467-9
Type: Journal Article/Review
Parent Publication: The Lancet Global Health
Issue: 1